AbbVie, maker of the world's best-selling drug, is buying Botox maker Allergan in a blockbuster deal. Here's what that says about the state of biopharma.
Focus
Get stories from Fortune delivered to your inbox
GO »
Autos
Design
Entertainment
Finance
Health
International
Leadership
Luxury
Retail
Tech